文献速递帕金森病与运动障碍认知障碍与痴呆

新皮质路易体病理与帕金森病痴呆平行但并非总是如此

Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always.
PubMed 文献 · Ann Neurol · 2022-11-22

本研究回顾了1996至2019年间华盛顿大学运动障碍中心165例经神经病理确诊的帕金森病患者的临床与病理资料,其中128例有临床痴呆。发现Braak路易体分期与痴呆诊断相关,而阿尔茨海默病神经病理改变(ADNC)和小血管病理严重程度与痴呆无关;6%的帕金森病痴呆患者无新皮质路易体,68%的无痴呆帕金森病患者却有新皮质路易体。

要点

  • Braak路易体分期与帕金森病痴呆诊断相关,ADNC和小血管病理严重程度与痴呆无关。
  • 6%的帕金森病痴呆患者无新皮质路易体,68%的无痴呆帕金森病患者有新皮质路易体。
  • 部分帕金森病痴呆患者既无新皮质路易体,也无ADNC或小血管病,提示其他因素参与。

核心结论

  • 新皮质路易体几乎总是伴随帕金森病患者的痴呆出现,但也出现在大多数无痴呆的帕金森病患者中。
  • 部分帕金森病痴呆患者没有新皮质路易体、ADNC或小血管病,因此与这些经典神经病理特征不直接相关的其他因素可能参与帕金森病痴呆。

研究设计与样本

  • 回顾性研究,纳入1996年至2019年间在华盛顿大学圣路易斯运动障碍中心就诊且有尸检资料的所有患者。
  • 纳入标准为基于神经病理诊断的帕金森病,共165例符合标准,其中128例有临床痴呆。
  • 采用逻辑回归和多变量协方差分析(MANCOVA)研究神经病理与痴呆的关系。

主要发现

  • 痴呆组与非痴呆组相比,运动起病平均年龄和死亡平均年龄更大,但平均疾病病程相当。
  • 14例患者运动症状起病至痴呆的间隔为1年或更短,符合可能或很可能路易体痴呆(DLB)的研究诊断标准。
  • Braak路易体分期与痴呆诊断相关,而ADNC和小血管病理的严重程度与痴呆诊断无关。
  • 诊断为DLB的个体病理与其他帕金森病痴呆患者无显著差异。
  • 6%的帕金森病痴呆患者无新皮质路易体;68%的无痴呆帕金森病患者有新皮质路易体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate the relationship between Parkinson's disease (PD) with dementia and cortical proteinopathies in a large population of pathologically confirmed patients with PD. METHODS: We reviewed clinical data from all patients with autopsy data seen in the Movement Disorders Center at Washington University, St. Louis, between 1996 and 2019. All patients with a diagnosis of PD based on neuropathology were included. We used logistic regression and multivariate analysis of covariance (MANCOVA) to investigate the relationship between neuropathology and dementia. RESULTS: A total of 165 patients with PD met inclusion criteria. Among these, 128 had clinical dementia. Those with dementia had greater mean ages of motor onset and death but equivalent mean disease duration. The delay between motor symptom onset and dementia was 1 year or less in 14 individuals, meeting research diagnostic criteria for possible or probable dementia with Lewy bodies (DLB). Braak Lewy body stage was associated with diagnosis of dementia, whereas severities of Alzheimer's disease neuropathologic change (ADNC) and small vessel pathology did not. Pathology of individuals diagnosed with DLB did not differ significantly from that of other patients with PD with dementia. Six percent of individuals with PD and dementia did not have neocortical Lewy bodies; and 68% of the individuals with PD but without dementia did have neocortical Lewy bodies. INTERPRETATION: Neocortical Lewy bodies almost always accompany dementia in PD; however, they also appear in most PD patients without dementia. In some cases, dementia may occur in patients with PD without neocortical Lewy bodies, ADNC, or small vessel disease. Thus, other factors not directly related to these classic neuropathologic features may contribute to PD dementia. ANN NEUROL 2023;93:184-195.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Martin WRW, Younce JR, Campbell MC, et al. Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always. Ann Neurol. 2022. PMID: 36331161. doi:10.1002/ana.26542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。